Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a newly emerging viral disease with fatal outcomes. However, no MERS-CoV-specific treatment is commercially available. Given the absence of previous structure-based drug discovery studies targeting MERS-CoV fusion proteins, this set of compo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomol Ther (Seoul)
Главные авторы: Kandeel, Mahmoud, Yamamoto, Mizuki, Al-Taher, Abdulla, Watanabe, Aya, Oh-hashi, Kentaro, Park, Byoung Kwon, Kwon, Hyung-Joo, Inoue, Jun-ichiro, Al-Nazawi, Mohammed
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Society of Applied Pharmacology 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7327142/
https://ncbi.nlm.nih.gov/pubmed/32126736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2019.202
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы